1. Home
  2. CDXS vs OPOF Comparison

CDXS vs OPOF Comparison

Compare CDXS & OPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXS
  • OPOF
  • Stock Information
  • Founded
  • CDXS 2002
  • OPOF 1922
  • Country
  • CDXS United States
  • OPOF United States
  • Employees
  • CDXS N/A
  • OPOF N/A
  • Industry
  • CDXS Major Chemicals
  • OPOF Major Banks
  • Sector
  • CDXS Industrials
  • OPOF Finance
  • Exchange
  • CDXS Nasdaq
  • OPOF Nasdaq
  • Market Cap
  • CDXS 254.3M
  • OPOF 210.8M
  • IPO Year
  • CDXS 2010
  • OPOF N/A
  • Fundamental
  • Price
  • CDXS $2.69
  • OPOF $39.87
  • Analyst Decision
  • CDXS Buy
  • OPOF
  • Analyst Count
  • CDXS 2
  • OPOF 0
  • Target Price
  • CDXS $11.00
  • OPOF N/A
  • AVG Volume (30 Days)
  • CDXS 819.6K
  • OPOF 13.8K
  • Earning Date
  • CDXS 08-11-2025
  • OPOF 07-30-2025
  • Dividend Yield
  • CDXS N/A
  • OPOF 1.40%
  • EPS Growth
  • CDXS N/A
  • OPOF 21.17
  • EPS
  • CDXS N/A
  • OPOF 1.70
  • Revenue
  • CDXS $49,815,000.00
  • OPOF $60,348,000.00
  • Revenue This Year
  • CDXS $12.53
  • OPOF N/A
  • Revenue Next Year
  • CDXS $22.54
  • OPOF N/A
  • P/E Ratio
  • CDXS N/A
  • OPOF $23.41
  • Revenue Growth
  • CDXS N/A
  • OPOF 3.33
  • 52 Week Low
  • CDXS $1.90
  • OPOF $17.02
  • 52 Week High
  • CDXS $6.08
  • OPOF $41.61
  • Technical
  • Relative Strength Index (RSI)
  • CDXS 45.92
  • OPOF 43.09
  • Support Level
  • CDXS $2.77
  • OPOF $40.35
  • Resistance Level
  • CDXS $3.39
  • OPOF $41.61
  • Average True Range (ATR)
  • CDXS 0.19
  • OPOF 0.58
  • MACD
  • CDXS -0.06
  • OPOF -0.16
  • Stochastic Oscillator
  • CDXS 13.58
  • OPOF 13.00

About CDXS Codexis Inc.

Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.

About OPOF Old Point Financial Corporation

Old Point Financial Corp functions in the financial services domain in the United States. As the holding company of The Bank and Trust, it is a nationally chartered trust and wealth management service, provider. Its suite of services includes commercial banking solutions such as loan, deposit and cash management, which are rendered through a chain of branches throughout the country. It operates through segments such as Bank, Wealth and Company.

Share on Social Networks: